Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study

Publisher： John Wiley & Sons Inc

E-ISSN： 1549-490x|23|1|7-15

ISSN： 1083-7159

Source： The Oncologist, Vol.23, Iss.1, 2018-01, pp. : 7-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Japanese Society for Cancer of the Colon and Rectum Guidelines 2010 for the treatment of colorectal cancer: comparison with western guidelines

By Ishiguro Megumi   Watanabe Toshiaki   Kotake Kenjiro   Sugihara Kenichi  

Colorectal Cancer, Vol. 2, Iss. 2, 2013-04 ,pp. : 179-190

Future Medicine

Access to resources Recommend Favorite

Oral multikinase inhibitor regorafenib for the treatment of patients with metastatic colorectal cancer

By Cremolini Chiara   Schirripa Marta   Loupakis Fotios   Falcone Alfredo  

Colorectal Cancer, Vol. 2, Iss. 5, 2013-10 ,pp. : 411-417

Future Medicine

Access to resources Recommend Favorite

Chemotherapy with bevacizumab for metastatic colorectal cancer: a retrospective review of 181 Japanese patients

By Saito Seiya   Hayashi Naoko   Sato Nobutaka   Iwatsuki Masaaki   Baba Yoshifumi   Sakamoto Yasuo   Miyamoto Yuji   Watanabe Masayuki   Yoshida Minoru   Sakai Kenji   Katsumori Takashi   Katahuchi Shigeru   Shigaki Nobuyuki   Yamada Kazutaka   Kimura Masami   Tanigawa Tomio   Takano Sadamu   Kuramoto Masafumi   Baba Hideo  

International Journal of Clinical Oncology, Vol. 18, Iss. 4, 2013-08 ,pp. : 689-695

Springer Publishing Company

Access to resources Recommend Favorite

FOLFIRI plus bevacizumab as a first-line treatment for Japanese patients with metastatic colorectal cancer: a JACCRO CC-03 multicenter phase II study

By Kochi Mitsugu   Akiyama Yuji   Aoki Tatsuya   Hagiwara Ken   Takahashi Takao   Hironaka Katsuji   Teranishi Futoshi   Osuka Fumihiko   Takeuchi Masahiro   Fujii Masashi   Nakajima Toshifusa  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 5, 2013-11 ,pp. : 1097-1102

Springer Publishing Company

Access to resources Recommend Favorite

Raltitrexed plus weekly oxaliplatin as first-line chemotherapy in metastatic colorectal cancer: A multicenter non-randomized phase II study

By Santini Daniele   Massacesi Cristian   D’Angelillo Rolando   Marcucci Fabiana   Campisi Costantino   Vincenzi Bruno   Pilone Alberta   Bianco Vincenzo   Bonsignori Maurizio   Tonini Giuseppe  

Medical Oncology, Vol. 21, Iss. 1, 2004-03 ,pp. : 59-66

Humana Press, Inc

Access to resources Recommend Favorite